Viruses have transformed our understanding of mammalian RNA processing, including facilitating the discovery of the methyl-7-guanosine (m7G) cap on the 5' end of RNAs. The m7G cap is required for RNAs to bind the eukaryotic translation
initiation factor eIF4E and associate with the translation machinery across plant and animal kingdoms. The potyvirus-derived viral genome-linked
protein (VPg) is covalently bound to the 5' end of viral genomic
RNA (gRNA) and associates with host
eIF4E for successful
infection. Divergent models to explain these observations proposed either an unknown mode of
eIF4E engagement or a competition of VPg for the m7G cap-binding site. To dissect these possibilities, we resolved the structure of VPg, revealing a previously unknown 3-dimensional (3D) fold, and characterized the VPg-eIF4E complex using NMR and biophysical techniques. VPg directly bound the cap-binding site of
eIF4E and competed for m7G cap analog binding. In human cells, VPg inhibited eIF4E-dependent
RNA export, translation, and oncogenic transformation. Moreover, VPg formed trimeric complexes with eIF4E-eIF4G,
eIF4E bound VPg-
luciferase RNA conjugates, and these VPg-
RNA conjugates were templates for translation. Informatic analyses revealed structural similarities between VPg and the human
kinesin EG5. Consistently, EG5 directly bound
eIF4E in a similar manner to VPg, demonstrating that this form of engagement is relevant beyond potyviruses. In all, we revealed an unprecedented modality for control and engagement of
eIF4E and show that VPg-
RNA conjugates functionally engage
eIF4E. As such, potyvirus VPg provides a unique model system to interrogate
eIF4E.